Renowned dTMS (Deep Transcranial Magnetic Stimulation) depression treatment provider, Achieve TMS, will being putting on a free open house event for the general public from 5:30pm to 7pm on July 22, 2019, at its new Irvine center in California, in order to celebrate its launch, and invite people to see what’s on offer.
So What is dTMS?
This refers to a neurostimulation and neuromodulation technique which is founded on the precept of the electromagnetic induction of an electrical field within the brain. The cortex region in the brain can be modulated up to a depth of 6 cm, and is thus able to regulate the activity of deeper neural circuits as well as the cerebral cortex itself.
This form of treatment is mainly utilized for treating patients with MDD (major depressive disorder), in cases where they remain drug-resistant. Moreover, it is also on trial to treat a broad spectrum of psychiatric disorders, among other conditions. So this natural form of treatment could potentially be very promising for: “major depression, autism, bipolar depression, auditory hallucinations, and negative symptoms of schizophrenia”.
The Achieve TMS Event
Throughout the course of the event, Drs. Shashita Inamdar and Manish Sheth, will inform the audience about the latest research on Deep Transcranial Magnetic Stimulation therapy for refractory depression. Visitors will also have a chance look at the treatment device, see how it works, and ask questions to the facility’s friendly medical management staff who are specialists in intricate mental health issues.
About Achieve TMS
This company is America’s most trusted provider of dTMS. Not only has it provided over 30,000 treatments thus far, there has been a very impressive remission rate of nearly half (49%), and a response rate of 70%.
Achieve TMS’ Irvine office is run in association with the Progeny Psychiatric Group. This was initially set up by Dr. Jason Kellogg, in order to offer patients and their families cutting-edge top quality care.
Achieve TMS & Progeny Psychiatric Group
In 2013, the US Food and Drug Administration approved Achieve TMS for treating individuals with depression. The company is also regarded as a highly trusted, leading dTMS provider.
The PPG (Progeny Psychiatric Group), comprises an organization of devoted specialists who provide quality care, and who work tirelessly to meet the requirements of communities, families, and individuals.